Drug
Triptorelin Pamoate
Triptorelin Pamoate: highest development phase Phase 3, developed by Ipsen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Ipsen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Triptorelin Pamoate 11.25mg NCT01715129 | Phase 3 | Prostate Cancer |
Latest
No recent events.
Follow Triptorelin Pamoate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.